Honghong Li1, Wenjuan Liu2, Jiemei Xie3. 1. Department of Public Health, Shandong Province Yantai City Yuhuangding Hospital, Yantai 264000, China. 2. Department of Gynecology, Shandong Province Yantai City Yuhuangding Hospital, Yantai 264000, China. 3. Department of Endocrinology, Shandong Province Yantai City Yuhuangding Hospital, Yantai 264000, China. Electronic address: xiejiemeiyt@yeah.net.
Abstract
OBJECTIVE: Inflammatory markers may be associated with mortality in the elderly population. We conducted this meta-analysis to evaluate the association of elevated circulating interleukin-6 levels with cardiovascular or all-cause mortality in the general elderly population. METHODS: A comprehensive literature search was conducted through the Pubmed and Embase databases until April 2016. Prospective observational studies that investigated the association of circulating interleukin-6 levels with cardiovascular or all-cause mortality in the elderly general population (aged 60 years or more) were included. Pooled risk ratio (RR) and 95% confidence intervals (CI) were calculated by the highest vs. the lowest interleukin-6 levels. RESULTS: Nine prospective studies involving 9087 participants were identified. When comparing the highest with the lowest interleukin-6 levels, the pooled RR of all-cause mortality and cardiovascular mortality were 1.49 (95% CI 1.33-1.67) and 1.69 (95% CI 1.27-2.25), respectively. Subgroup analysis indicated the effects of interleukin-6 on all-cause mortality were consistently observed in sample sizes, region, durations of follow-up, interleukin-6 cutoff value and number of adjusted for covariates subgroups. CONCLUSIONS: This meta-analysis indicates that elevated circulating interleukin-6 levels are independently associated with greater risk of cardiovascular and all-cause mortality in the general elderly population.
OBJECTIVE: Inflammatory markers may be associated with mortality in the elderly population. We conducted this meta-analysis to evaluate the association of elevated circulating interleukin-6 levels with cardiovascular or all-cause mortality in the general elderly population. METHODS: A comprehensive literature search was conducted through the Pubmed and Embase databases until April 2016. Prospective observational studies that investigated the association of circulating interleukin-6 levels with cardiovascular or all-cause mortality in the elderly general population (aged 60 years or more) were included. Pooled risk ratio (RR) and 95% confidence intervals (CI) were calculated by the highest vs. the lowest interleukin-6 levels. RESULTS: Nine prospective studies involving 9087 participants were identified. When comparing the highest with the lowest interleukin-6 levels, the pooled RR of all-cause mortality and cardiovascular mortality were 1.49 (95% CI 1.33-1.67) and 1.69 (95% CI 1.27-2.25), respectively. Subgroup analysis indicated the effects of interleukin-6 on all-cause mortality were consistently observed in sample sizes, region, durations of follow-up, interleukin-6 cutoff value and number of adjusted for covariates subgroups. CONCLUSIONS: This meta-analysis indicates that elevated circulating interleukin-6 levels are independently associated with greater risk of cardiovascular and all-cause mortality in the general elderly population.
Authors: Setor K Kunutsor; Sae Young Jae; Sudhir Kurl; Jussi Kauhanen; Jari A Laukkanen Journal: Eur J Epidemiol Date: 2022-10-18 Impact factor: 12.434
Authors: Páraic S O'Súilleabháin; Nicholas A Turiano; Denis Gerstorf; Martina Luchetti; Stephen Gallagher; Amanda A Sesker; Antonio Terracciano; Angelina R Sutin Journal: Brain Behav Immun Date: 2021-02-09 Impact factor: 7.217
Authors: G Masala; B Bendinelli; C Della Bella; M Assedi; S Tapinassi; I Ermini; D Occhini; M Castaldo; C Saieva; S Caini; M M D'Elios; D Palli Journal: Sci Rep Date: 2020-12-14 Impact factor: 4.379
Authors: Kamal Awad; Maged Mohammed; Mahmoud Mohamed Zaki; Abdelrahman I Abushouk; Gregory Y H Lip; Michael J Blaha; Carl J Lavie; Peter P Toth; J Wouter Jukema; Naveed Sattar; Maciej Banach Journal: BMC Med Date: 2021-06-22 Impact factor: 8.775
Authors: Colton Leavitt; Neil A Zakai; Paul Auer; Mary Cushman; Ethan M Lange; Emily B Levitan; Nels Olson; Timothy A Thornton; Russell P Tracy; James G Wilson; Leslie A Lange; Alex P Reiner; Laura M Raffield Journal: PLoS One Date: 2020-04-02 Impact factor: 3.240